RNA modifications shape innate immunity and cellular adaptation during bacterial respiratory infection - Scorecard - MDSpire

RNA modifications shape innate immunity and cellular adaptation during bacterial respiratory infection

  • By

  • Martina M. Ivanova

  • Petya A. Dimitrova

  • Milena N. Leseva

  • June 5, 2026

  • 0 min

Share

Clinical Scorecard: RNA Modifications Influence Innate Immune Responses and Cellular Adaptation in Bacterial Respiratory Infections

At a Glance

CategoryDetail
ConditionBacterial respiratory infections, particularly those caused by Pseudomonas aeruginosa
Key MechanismsRNA modifications regulating bacterial fitness and pathogenicity, and controlling host innate immune responses
Target PopulationPatients with bacterial respiratory infections, including those with chronic diseases like cystic fibrosis, COPD, and lung cancer
Care SettingClinical settings managing bacterial infections and sepsis

Key Highlights

  • Gram-negative bacteria are significant pathogens linked to severe respiratory infections.
  • RNA modifications play a crucial role in both bacterial pathogenicity and host immune responses.
  • Dysregulation of epitranscriptomic modifications can lead to exacerbated infectious diseases.
  • Carbapenem-resistant Pseudomonas aeruginosa is a high-priority pathogen according to WHO.
  • Physiologically-relevant in vitro models can complement in vivo studies of bacterial infections.

Guideline-Based Recommendations

Diagnosis

  • Focus on identifying bacterial infections through culture and sensitivity testing.

Management

  • Consider the role of RNA modifications in developing new antimicrobial therapies.

Monitoring & Follow-up

  • Monitor for signs of sepsis and immune dysregulation in infected patients.

Risks

  • Be aware of the increasing antimicrobial resistance, particularly in Gram-negative bacteria.

Patient & Prescribing Data

Patients with bacterial respiratory infections and chronic conditions

Understanding RNA modifications may lead to novel therapeutic targets.

Clinical Best Practices

  • Utilize high-throughput mapping of RNA modifications to inform treatment strategies.
  • Incorporate epitranscriptomic insights into the management of bacterial infections.

Related Resources & Content

Original Source(s)

Related Content